Skip to main content
logo
RedHill Biopharma logo
RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL · Real-Time Price · USD
0.5406
+0.0016 (0.30%)
Oct 12, 2026, 12:22 PM EDT - Market open

RedHill Biopharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-0.29--61.885.76
Revenue Growth
-----27.94%33.25%
Gross Profit
-0.29--28.4636.35
Operating Income
-7.99-7.91-6.48-9.55-42.84-81.14
Net Income
-2.4-0.43-8.2723.92-71.67-97.74
Earnings Per Share
--0.14-6.7192.30-1162.89-2100.80
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
5.163.974.625.5719.9838
Total Debt
1.081.070.361.17122.6987.81
Net Cash (Debt)
4.082.94.264.4-102.71-49.81
Net Cash Growth
40.78%-31.92%-3.07%---
Net Cash Per Share
-0.923.4616.96-1666.53-1070.52

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-7.76-7.19-8.94-16.82-29.19-65.05
Capital Expenditures
-0.02-0.01-0.01-0.01-0.2-0.12
Free Cash Flow
-7.78-7.2-8.94-16.83-29.38-65.16
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%--46.06%42.39%
Operating Margin
--2765.38%---69.33%-94.61%
Pretax Margin
--2825.17%---115.97%-113.98%
Profit Margin
--150.00%---115.97%-113.98%
FCF Margin
--2516.08%---47.55%-75.98%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
---1.20--
PS Ratio
-18.34--0.211.58